Al Janaby T, Khelwatty S, Bagwan I, Abbassi-Ghadi N, Modjtahedi H. Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma. World J Oncol. Published online April 5, 2025. doi:10.14740/wjon2552